BioMimetic Pharmaceuticals has named Larry Bullock the company’s chief financial officer and Charles Hart chief scientific officer and vice president of orafacial healthcare.

Bullock most recently served as CFO and vice president of finance and administration at Colorado-based Ribozyme Pharmaceuticals. Hart has served in several management positions at ZymoGenetics Inc., including director of protein biochemistry, senior director of business development and strategic planning.

Recommended for you